Michele Di Stefano
NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo
Di Stefano, Michele; Loreto, Andrea; Orsomando, Giuseppe; Mori, Valerio; Zamporlini, Federica; Hulse, Richard P.; Webster, Jamie; Donaldson, Lucy F.; Gering, Martin; Raffaelli, Nadia; Coleman, Michael P.; Gilley, Jonathan; Conforti, Laura
Authors
Andrea Loreto
Giuseppe Orsomando
Valerio Mori
Federica Zamporlini
Richard P. Hulse
Jamie Webster
LUCY DONALDSON Lucy.Donaldson@nottingham.ac.uk
Professor of Sensory Physiology
MARTIN GERING martin.gering@nottingham.ac.uk
Assistant Professor
Nadia Raffaelli
Michael P. Coleman
Jonathan Gilley
Laura Conforti
Abstract
Axons require the axonal NAD-synthesizing enzyme NMNAT2 to survive. Injury or genetically-induced depletion of NMNAT2 triggers axonal degeneration or defective axon growth. We have previously proposed that axonal NMNAT2 primarily promotes axon survival by maintaining low levels of its substrate NMN, rather than generating NAD; however, this is still debated. NMN deamidase, a bacterial enzyme, shares NMN-consuming activity with NMNAT2, but not NAD-synthesizing activity, and delays axon degeneration in primary neuronal cultures. Here, we show that NMN deamidase can also delay axon degeneration in zebrafish larvae and in transgenic mice. Like overexpressed NMNATs, NMN deamidase reduces NMN accumulation in injured mouse sciatic nerves and preserves some axons for up to 3 weeks, even when expressed at a low level. Remarkably, NMN deamidase also rescues axonal outgrowth and perinatal lethality in mice lacking NMNAT2 in a dose-dependent manner. These data further support a pro-degenerative effect of accumulating NMN in axons in vivo. The NMN deamidase mouse will be an important tool to further probe the mechanisms underlying Wallerian degeneration and its prevention.
Citation
Di Stefano, M., Loreto, A., Orsomando, G., Mori, V., Zamporlini, F., Hulse, R. P., …Conforti, L. (2017). NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo. Current Biology, 27(6), 784-794. https://doi.org/10.1016/j.cub.2017.01.070
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 1, 2017 |
Online Publication Date | Mar 2, 2017 |
Publication Date | Mar 20, 2017 |
Deposit Date | Feb 27, 2017 |
Publicly Available Date | Mar 2, 2017 |
Journal | Current Biology |
Print ISSN | 0960-9822 |
Electronic ISSN | 1879-0445 |
Publisher | Cell Press |
Peer Reviewed | Peer Reviewed |
Volume | 27 |
Issue | 6 |
Pages | 784-794 |
DOI | https://doi.org/10.1016/j.cub.2017.01.070 |
Keywords | axon degeneration; Wallerian degeneration; NMNAT2; NMNAT; NMN; NAD; NMN deamidase; WLDs; SARM1; neurodegeneration |
Public URL | https://nottingham-repository.worktribe.com/output/848439 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S0960982217301355 |
Additional Information | This article is maintained by: Elsevier; Article Title: NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency InVivo; Journal Title: Current Biology; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cub.2017.01.070; Content Type: article; Copyright: © 2017 The Authors. Published by Elsevier Ltd. |
Files
1-s2.0-S0960982217301355-main.pdf
(3.9 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
(2014)
Journal Article
Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A
(2015)
Journal Article